The document also adds that the proposed changes by the WHO could give people the wrong idea, leading them to think that the current Schedule IV stance impedes research and that the international framework isn’t compatible with research. What they’re basically saying is that even if the United States acknowledges the benefits of reclassifying cannabis, the government is worried about how it would turn out.
With Zoap, Cadillac Rainbow, and Blueberry Caviar. The post Leafly Buzz: 12 hot strains to…
Follow our links to verified aid groups. The post LA’s cannabis community steps up for…
As you might imagine, telling Americans they can't have their guns AND their ganja isn't…
The new ILGM is a veritable treasure trove of expert knowledge that’ll help you find…
edibles, tinctures, beverages, and cannabis oil to name a few. Now, the results of a…
Ask any cannabis enthusiast about their relationship with music while high, and you'll likely get…